SG161234A1 - A method and composition for nutritionally improving glucose control and insulin action - Google Patents

A method and composition for nutritionally improving glucose control and insulin action

Info

Publication number: SG161234A1
Authority: SG; Singapore
Prior art keywords: composition; source; improving glucose; glucose control; insulin action
Prior art date: 2005-04-06

Application number

SG201002347-1A

Other languages

English (en)

Inventor

Kenneth C Hayes

Norman Alan Greenberg

John P Troup

Anne L Falk

Gianni Biolo

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-06

Filing date

2006-04-04

Publication date

2010-05-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36661519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG161234(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-04-04 Application filed by Novartis Ag filed Critical Novartis Ag

2010-05-27 Publication of SG161234A1 publication Critical patent/SG161234A1/en

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 2
102000004877 Insulin Human genes 0.000 title abstract 2
108090001061 Insulin Proteins 0.000 title abstract 2
239000008103 glucose Substances 0.000 title abstract 2
229940125396 insulin Drugs 0.000 title abstract 2
150000001720 carbohydrates Chemical class 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Natural Medicines & Medicinal Plants (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Hematology (AREA)
Botany (AREA)
Obesity (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pediatric Medicine (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)

SG201002347-1A 2005-04-06 2006-04-04 A method and composition for nutritionally improving glucose control and insulin action SG161234A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66863305P	2005-04-06	2005-04-06

Publications (1)

Publication Number	Publication Date
SG161234A1 true SG161234A1 (en)	2010-05-27

Family

ID=36661519

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG201002347-1A SG161234A1 (en)	2005-04-06	2006-04-04	A method and composition for nutritionally improving glucose control and insulin action

Country Status (16)

Country	Link
US (2)	US8067359B2 (fr)
EP (3)	EP2243383A3 (fr)
JP (3)	JP5788631B2 (fr)
CN (2)	CN101175416A (fr)
AU (2)	AU2006231557B2 (fr)
BR (1)	BRPI0608610A2 (fr)
CA (1)	CA2601427C (fr)
DK (1)	DK1868454T3 (fr)
ES (1)	ES2419205T3 (fr)
IL (1)	IL186005A0 (fr)
MX (1)	MX2007012450A (fr)
PT (1)	PT1868454E (fr)
RU (1)	RU2421076C2 (fr)
SG (1)	SG161234A1 (fr)
WO (1)	WO2006108008A2 (fr)
ZA (1)	ZA200707825B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8283327B2 (en)	2005-03-19	2012-10-09	Kneller Bruce W	Palatinose for enhancing dietary supplement and pharmaceutical delivery
EP2243383A3 (fr) *	2005-04-06	2011-02-16	Nestec S.A.	Méthode et composition diététiques pour améliorer le contrôle de la glycémie et de l'action de l'insuline
CA2655665A1 (fr) *	2006-05-26	2007-12-06	Nestec S.A.	Procedes d'utilisation d'extrait de touchi et compositions nutritionnelles d'extrait de touchi associees
WO2008054193A1 (fr) *	2006-11-02	2008-05-08	N.V. Nutricia	Produits alimentaires contenant des oligomères à base de saccharide
WO2009087988A1 (fr) *	2008-01-09	2009-07-16	Nutri Co., Ltd.	Composition pour réduire le stress oxydatif et/ou les effets secondaires au cours d'une chimiothérapie anticancéreuse ou améliorer l'état nutritionnel au cours d'une chimiothérapie anticancéreuse
US8071143B2 (en) *	2008-04-02	2011-12-06	Brandeis University	Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
WO2009135959A1 (fr) *	2008-05-07	2009-11-12	Katry Inversiones, S.L.	Produit alimentaire pour la nutrition par voie entérale ou orale du patient diabétique
WO2009135960A1 (fr) *	2008-05-07	2009-11-12	Katry Inversiones, S.L.	Mélange d'hydrates de carbone et son utilisation pour préparer un produit destiné à l'alimentation par voie orale ou entérale
KR101567465B1 (ko)	2008-08-27	2015-11-09	피티. 덱사 메디카	인슐린 민감성 강화제 및 항당뇨병제로서의 식물 추출물
EP2350274B1 (fr)	2008-10-21	2019-01-23	The General Hospital Corporation	Transplantation de cellules
US8114445B2 (en) *	2008-11-07	2012-02-14	Reliv International Inc.	Dietary supplement for promoting wellness and weight loss and methods of administering the same
US20100179089A1 (en) *	2009-01-13	2010-07-15	Deutz Nicolaas E P	Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
KR20110124780A (ko)	2009-02-24	2011-11-17	리터 파마슈티컬즈 인코오포레이티드	프리바이오틱 제제 및 사용 방법
WO2010110640A1 (fr)	2009-03-24	2010-09-30	Universiti Putra Malaysia	Composition nutraceutique antidiabétique à partir d'extrait de feuilles de palmier
EP2311486A1 (fr) *	2009-10-07	2011-04-20	Nestec S.A.	GLP-2 en utilisation pour la récupération intestinale et musculaire
US9144586B2 (en)	2010-04-07	2015-09-29	Incube Labs, Llc	Method for treating glucose related disorders using stem cell-derived gastro-intestinal cells
CN103068259B (zh) *	2010-07-14	2015-05-20	甜糖（曼海姆/奥克森富特）股份公司	异麦芽酮糖用于增强精神表现
JP6072684B2 (ja)	2010-08-06	2017-02-01	ザジェネラルホスピタルコーポレーションディー／ビー／エイマサチューセッツジェネラルホスピタル	細胞処置システムおよび細胞処置装置
CN101926431A (zh) *	2010-08-23	2010-12-29	贵阳高新创嘉创业服务有限公司	一种具有保健功能的组合物及其制备方法和用途
CN102007952A (zh) *	2010-09-26	2011-04-13	深圳职业技术学院	营养棒及其制备方法
MX2014001837A (es) *	2011-08-16	2014-02-27	Abbott Lab	Composiciones nutricionales que comprenden una fibra viscosa soluble y un extracto vegetal que contiene polifenol.
WO2013137750A1 (fr) *	2012-03-13	2013-09-19	Sapporo Holdings Limited	Produit alimentaire ou à boire équilibré en termes nutritionnels
WO2013173719A1 (fr) *	2012-05-18	2013-11-21	Metaproteomics, Llc	Compositions de phytonutriments et procédés d'utilisation
EP2953639B1 (fr)	2013-02-06	2021-06-02	Brandeis University	Traitement d'une altération de l'adn et de dysfonctionnement mitochondrial au moyen de jus de fruit de palmier
CN105431055A (zh)	2013-07-01	2016-03-23	南加利福尼亚大学	作为糖尿病食疗的禁食条件
ITMI20131467A1 (it) *	2013-09-06	2015-03-07	Sofar Spa	Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
CA2930919C (fr) *	2013-11-19	2021-11-23	Omniblend Innovation Pty Ltd	Composition comprenant des proteines et des fibres de fenugrec, et utilisations connexes pour controler les niveaux de glycemie postprandiaux
CN106211757B (zh)	2014-01-17	2022-06-07	康奈尔大学	使用维甲酸受体激动剂治疗代谢综合征相关病况的方法
US11191755B2 (en)	2014-01-17	2021-12-07	Cornell University	Compositions and methods for providing cardioprotective effects
MA39710A (fr)	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
HK1258621A1 (zh) *	2016-01-12	2019-11-15	南加利福尼亚大学	长期禁食模仿作为多发性骨髓瘤和其他癌症的膳食治疗的用途
MA45327A (fr)	2016-05-13	2019-03-20	Sofar Spa	Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr)	2016-06-08	2019-04-17	Sofar Spa	Nouvelle utilisation médicale de probiotiques
EP3468670B1 (fr)	2016-06-10	2023-12-13	University of Copenhagen	Régime prédéterminé pour l'induction de perte de poids et de prévention de la prise de poids
WO2017213961A1 (fr) *	2016-06-10	2017-12-14	Gelesis Llc	Procédés d'induction de perte de poids, de traitement de l'obésité et de prévention de la prise de poids
CN106490614A (zh) *	2016-10-31	2017-03-15	北京万源普达医疗科技有限公司	一种组合物及其作为糖尿病全营养配方食品的应用
IT201600122724A1 (it)	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
IT201600127498A1 (it)	2016-12-16	2018-06-16	Sofar Spa	Probiotici per uso nella diverticolosi e malattia diverticolare
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110891982B (zh)	2017-04-17	2023-12-22	芝加哥大学	向肠道递送短链脂肪酸以用于人体保健和疾病治疗的聚合物材料
US12110562B2 (en)	2017-06-01	2024-10-08	University Of Copenhagen	Compositions and methods for predicting and promoting weight loss
BR112020002419A2 (pt)	2017-08-14	2020-07-28	Axcella Health Inc.	aminoácido para o tratamento de doença do fígado
EP3810123A1 (fr)	2018-06-20	2021-04-28	Axcella Health Inc.	Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
JP2022511693A (ja) *	2018-12-13	2022-02-01	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	動物における代謝健康を増進する方法
CN109528734A (zh) *	2019-01-24	2019-03-29	华纳时代健康科技（武汉）股份有限公司	一种复合营养组合物及其制备方法
CN110200276B (zh) *	2019-06-27	2023-04-07	刘东波	基于中药营养的组合物
US11751597B2 (en)	2019-11-05	2023-09-12	Alfasigma S.P.A.	Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
WO2022049130A1 (fr)	2020-09-01	2022-03-10	Shell Internationale Research Maatschappij B.V.	Composition d'huile moteur
CN114631628A (zh) *	2020-12-15	2022-06-17	中国科学院上海营养与健康研究所	一种增加血液fgf21浓度的方法
CN114794487A (zh) *	2021-01-22	2022-07-29	中国科学院上海营养与健康研究所	一种治疗糖尿病的方法
CN113785915A (zh) *	2021-08-05	2021-12-14	中山大学	一种甜味敏感的食物配方及其动物模型的构建方法
CN113521277A (zh) *	2021-08-27	2021-10-22	四川力量科技有限公司	一种康复糖尿病的产品及其制备方法
CN116473125A (zh) *	2022-01-17	2023-07-25	内蒙古伊利实业集团股份有限公司	一种缓释碳水组合物以及应用
CN116549428B (zh) *	2023-06-20	2025-05-16	郑州大学	4-羟基异亮氨酸的新用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8317248D0 (en) *	1983-06-24	1983-07-27	Wyeth John & Brother Ltd	Fat compositions
US6140304A (en) *	1988-09-28	2000-10-31	Eicotech Corporation	Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
CA2173780A1 (fr) *	1995-06-01	1996-12-02	Randy Grote	Methode d'alimentation a l'aide de compositions sous diverses formes
MY115050A (en) *	1995-10-16	2003-03-31	Mead Johnson Nutrition Co	Diabetic nutritional product having controlled absorption of carbohydrate
EP0780055B1 (fr) *	1995-10-27	2002-12-11	Societe Des Produits Nestle S.A.	Composition de café nutritive
EP0843972B1 (fr) *	1996-11-20	2002-07-31	N.V. Nutricia	Composition nutritionnelle comprenant des corps gras pour le traitement du syndrome métabolique
ES2206821T3 (es) *	1997-06-23	2004-05-16	Societe Des Produits Nestle S.A.	Uso de una composicion nutritiva para la preparacion de una composicion liquida para diabeticos.
US5932258A (en) *	1998-04-06	1999-08-03	The Iams Company	Composition and process for improving glucose metabolism in companion animals
JP2000264844A (ja) *	1999-01-11	2000-09-26	Otsuka Pharmaceut Factory Inc	腎疾患患者用栄養組成物
US6440931B1 (en) *	1999-02-23	2002-08-27	Natural Corporation	Conjugated linoleic acid in treatment and prophylaxis of diabetes
US6592863B2 (en) *	2000-08-22	2003-07-15	Nestec S.A.	Nutritional composition
CN100456962C (zh) *	2001-02-09	2009-02-04	荷兰联合利华有限公司	含大豆蛋白和抑制素的食物制品
US6605310B2 (en) *	2001-06-06	2003-08-12	Nestec S.A.	Calorically dense liquid oral supplement
MY135783A (en) *	2001-09-07	2008-06-30	Meiji Dairies Corp	Nutritional composition for controlling blood sugar level
JP2007527400A (ja) *	2003-07-15	2007-09-27	ネステクソシエテアノニム	高繊維高カロリーの液状又は粉末状栄養組成物
EP2243383A3 (fr) *	2005-04-06	2011-02-16	Nestec S.A.	Méthode et composition diététiques pour améliorer le contrôle de la glycémie et de l'action de l'insuline

2006
- 2006-04-04 EP EP10004584A patent/EP2243383A3/fr not_active Withdrawn
- 2006-04-04 WO PCT/US2006/012576 patent/WO2006108008A2/fr not_active Ceased
- 2006-04-04 PT PT67492900T patent/PT1868454E/pt unknown
- 2006-04-04 MX MX2007012450A patent/MX2007012450A/es active IP Right Grant
- 2006-04-04 EP EP10004583A patent/EP2241195A1/fr not_active Withdrawn
- 2006-04-04 RU RU2007140731/13A patent/RU2421076C2/ru not_active IP Right Cessation
- 2006-04-04 ES ES06749290T patent/ES2419205T3/es active Active
- 2006-04-04 CA CA2601427A patent/CA2601427C/fr active Active
- 2006-04-04 US US11/910,817 patent/US8067359B2/en active Active
- 2006-04-04 EP EP06749290A patent/EP1868454B1/fr not_active Revoked
- 2006-04-04 DK DK06749290.0T patent/DK1868454T3/da active
- 2006-04-04 JP JP2008505477A patent/JP5788631B2/ja active Active
- 2006-04-04 BR BRPI0608610-1A patent/BRPI0608610A2/pt not_active Application Discontinuation
- 2006-04-04 SG SG201002347-1A patent/SG161234A1/en unknown
- 2006-04-04 CN CNA2006800167910A patent/CN101175416A/zh active Pending
- 2006-04-04 CN CN201510501576.0A patent/CN105394748A/zh active Pending
- 2006-04-04 AU AU2006231557A patent/AU2006231557B2/en active Active
2007
- 2007-09-13 ZA ZA200707825A patent/ZA200707825B/xx unknown
- 2007-09-17 IL IL186005A patent/IL186005A0/en unknown
2010
- 2010-07-12 AU AU2010202933A patent/AU2010202933A1/en not_active Abandoned
2011
- 2011-07-22 US US13/188,911 patent/US8697630B2/en active Active
2013
- 2013-02-15 JP JP2013028114A patent/JP2013100353A/ja not_active Withdrawn
2015
- 2015-07-23 JP JP2015146014A patent/JP2015187182A/ja active Pending

Also Published As

Publication number	Publication date
PT1868454E (pt)	2013-04-03
CN105394748A (zh)	2016-03-16
RU2421076C2 (ru)	2011-06-20
WO2006108008A2 (fr)	2006-10-12
MX2007012450A (es)	2008-02-12
RU2007140731A (ru)	2009-05-20
US20080193603A1 (en)	2008-08-14
WO2006108008A3 (fr)	2007-01-18
AU2010202933A1 (en)	2010-07-29
ES2419205T3 (es)	2013-08-19
DK1868454T3 (da)	2013-04-02
EP2243383A2 (fr)	2010-10-27
US8067359B2 (en)	2011-11-29
EP1868454A2 (fr)	2007-12-26
JP2015187182A (ja)	2015-10-29
JP5788631B2 (ja)	2015-10-07
EP2243383A3 (fr)	2011-02-16
CA2601427A1 (fr)	2006-10-12
JP2013100353A (ja)	2013-05-23
JP2008535840A (ja)	2008-09-04
US8697630B2 (en)	2014-04-15
ZA200707825B (en)	2009-10-28
CN101175416A (zh)	2008-05-07
EP1868454B1 (fr)	2013-03-06
AU2006231557A1 (en)	2006-10-12
US20110305791A1 (en)	2011-12-15
CA2601427C (fr)	2013-06-11
IL186005A0 (en)	2008-01-20
HK1113289A1 (en)	2008-10-03
BRPI0608610A2 (pt)	2010-01-19
AU2006231557B2 (en)	2010-09-09
EP2241195A1 (fr)	2010-10-20

Publication	Publication Date	Title
SG161234A1 (en)	2010-05-27	A method and composition for nutritionally improving glucose control and insulin action
ES2171077T3 (es)	2002-08-16	Composicion para mejorar el metabolismo de la glucosa y de la insulina en animales de compañia.
WO2006083328A3 (fr)	2006-12-14	Surfaces biologiquement actives et leurs procedes d'utilisation
WO2003080545A3 (fr)	2004-01-22	Acides phenylacetiques substitues
WO2006119467A3 (fr)	2006-12-28	Modification d'activite de proteine
WO2008013737A3 (fr)	2008-11-06	Compositions pour la reprogrammation d'une cellule et leurs utilisations
WO2009051706A3 (fr)	2009-12-17	Composés peptidiques pour le traitement de l'obésité et de la résistance à l'insuline
WO2006091589A3 (fr)	2007-10-11	Systeme et procede de distribution coordonnee de services de sante et de services personnalises
WO2005103002A3 (fr)	2006-02-02	Nouveaux composes d'alcyne a effet antagoniste vis-a-vis de mch et medicaments contenant ces composes
WO2004089290A3 (fr)	2006-09-08	Nouvelles compositions probiotiques et leurs methodes d'utilisation
TW200740379A (en)	2007-11-01	Nutrition for obese patients
AU2002353658A1 (en)	2003-06-30	Method of treating obesity, overweight, diabetes, or fluctuations in blood insuline or glucose levels
WO2005113016A3 (fr)	2006-05-04	Modulation de l’expression de la glucose-6-phosphatase translocase
WO2006128125A3 (fr)	2007-08-02	Methodes et compositions pour stimuler le captage du glucose dans des cellules musculaires et pour traiter des maladies
IL172898A0 (en)	2006-06-11	Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
TNSN05065A1 (en)	2007-05-14	Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
WO2005096837A3 (fr)	2006-04-27	Composition alimentaire therapeutique ou complement nutritif pret a l'emploi et procede de fabrication associe
EP1617735A4 (fr)	2010-09-01	Composition proteique musculaire animale fonctionnelle a faible taux de cholesterol et procede associe
WO2004069194A3 (fr)	2004-11-04	Compositions et procedes pour traiter le diabete
TW200501975A (en)	2005-01-16	An agent for upregulating physiological function during exercise
CY1115306T1 (el)	2017-01-04	Συνθεσεις και χρησεις αυτων
PL1753309T3 (pl)	2011-04-29	Kompozycje spożywcze zawierające kreatynę
WO2007146559A3 (fr)	2008-02-21	Composition nutritionnelle et son procédé de fabrication
WO2006017171A3 (fr)	2009-06-11	Methodes de diagnostic et de traitement de l'obesite, du diabete et de l'insulinoresistance
Baek et al.	2007	Effects of an 8-week combined training of walking and rope skipping on body composition, physical fitness, blood lipid profiles, and growth hormone in elementary students